共 50 条
- [21] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
- [22] HEPARIN RESISTANCE DURING CARDIOPULMONARY BYPASS JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 86 (04): : 633 - 633
- [23] Heparin management during cardiopulmonary bypass JOURNAL OF CARDIOVASCULAR SURGERY, 2001, 42 (03): : 431 - 433
- [25] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1984, 14 (06): : 474 - 479
- [26] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
- [27] CLINICAL-EXPERIENCE WITH THE ACTIVATED CLOTTING TIME FOR THE CONTROL OF HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1980, 79 (01): : 97 - 102
- [28] PLASMA VASOPRESSIN LEVELS DURING AND AFTER CARDIOPULMONARY BYPASS IN MAN MEDICAL BIOLOGY, 1986, 64 (05): : 289 - 292
- [29] Effect of aprotinin on plasma fibronectin levels during cardiopulmonary bypass ANNALS OF THORACIC SURGERY, 1997, 63 (01): : 64 - 67
- [30] FRESH-FROZEN PLASMA - A SOLUTION TO HEPARIN RESISTANCE DURING CARDIOPULMONARY BYPASS ANNALS OF THORACIC SURGERY, 1984, 37 (06): : 466 - 468